2020
DOI: 10.1016/s2468-2667(20)30191-2
|View full text |Cite|
|
Sign up to set email alerts
|

Cardiovascular risk factors in China: a nationwide population-based cohort study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
104
2
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 150 publications
(126 citation statements)
references
References 23 publications
5
104
2
1
Order By: Relevance
“…Also, another study was done in the Saudi population show (32.1%) had a high total cholesterol level [25]. In China the prevalence of high cholesterol was (31•0%) and the prevalence in male was 31•2% and female 30•6% [24]. On the other hand, our results were slightly higher in comparison to study done in Al-Qassim, KSA.…”
Section: Fig 5 the Percentage Of Participants Who Are Consuming Daily Salts And Coffeecontrasting
confidence: 69%
See 1 more Smart Citation
“…Also, another study was done in the Saudi population show (32.1%) had a high total cholesterol level [25]. In China the prevalence of high cholesterol was (31•0%) and the prevalence in male was 31•2% and female 30•6% [24]. On the other hand, our results were slightly higher in comparison to study done in Al-Qassim, KSA.…”
Section: Fig 5 the Percentage Of Participants Who Are Consuming Daily Salts And Coffeecontrasting
confidence: 69%
“…On the other hand, study in Emirates represented high prevalence of DM (42.8%) either for males or females [23]. The prevalence of DM in China in both rural and urban areas was (7.8%) and the prevalence in urban was higher (9%) in comparison to rural (7.1%) [24].…”
Section: Fig 5 the Percentage Of Participants Who Are Consuming Daily Salts And Coffeementioning
confidence: 99%
“…Evidence suggests the risk of CVD varies greatly across different regions in China (34). The patients in Hou et al were recruited from six cities in China (Beijing, Shanghai, Guangzhou, Hangzhou, Wuhan, and Xian), whilst all patients in the HD/HP trial were recruited from Shanghai, which is in the region with the lowest risk of CVD (35). Hou et al is a retrospective cohort study whilst the HD/HP trial is a randomized trial, and it has been reported that patients participating in trials experienced better outcomes compared with those outside trials (36,37).…”
Section: The Main Findings and Interpretationmentioning
confidence: 99%
“…Obesity is a major public health issue in China and all over the world [ 1 ]. Although Asia has reportedly the lowest rate of obesity and overweight, there is an alarmingly increasing trend in the past decades, with the prevalence of overweight and obesity increasing from 12.6% in 1980 to 30.5% in 2015 [ 2 , 3 ].…”
Section: Introductionmentioning
confidence: 99%